We also observed a borderline significant positive association with risk of pancreatic cancer for those with higher levels of CRP (≥10 mg/L) compared to those with CRP levels < 10 mg/L [HR: 1.32 (95% CI 1.00–1.74)]. This evidence concerns the gene CRP and pancreatic neoplasm.